Filed with ASX · · 50 pages · English
Cynata Therapeutics Limited has filed a prospectus for a non-accelerated, renounceable entitlement offer, allowing eligible shareholders to acquire new shares and options at a specified price to raise funds. The offer includes a provision for underwriter options and is fully underwritten by Caravel Securities Pty Ltd. The prospectus is dated and lodged with the Australian Securities and Investments Commission, and it emphasizes the speculative nature of the investment.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
On 6ix: 6ix.com/news/prospectus-324
cytl0001_2100021_207.docx CYNATA THERAPEUTICS LIMITED ACN 104 037 372 PROSPECTUS For a non-accelerated, renounceable pro rata entitlement offer of 3 New Shares for every 8 Shares held by Eligible Shareholders, and one free attaching Entitlement Option for every 3 New Shares issued, at...
Cynata Therapeutics Limited on 6ix
Follow Cynata Therapeutics into a list and get an email when it puts out news.
Follow Cynata Therapeutics